<qa>  What will be documented at vitamin D administration stages?vii Potential confounders: Haemoglobin will be maintained between 10-13gm. Use of Erythropoietin stimulating agents, dosefrequency of iron replacement and any blood transfusion will be documented. Office blood pressure as per BHS guidelines will be documented at vitamin D administration stages. Changes in anti-hypertensive medications over the follow-up period will be noted. In addition the following parameters will be assessed at 0, 20 and 40 weeks: 